These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15388436)

  • 1. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.
    Corvaisier S; Charpiat B; Mounier C; Wallon M; Leboucher G; Al Kurdi M; Chaulet JF; Peyron F
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3794-800. PubMed ID: 15388436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
    Trenque T; Simon N; Villena I; Chemla C; Quereux C; Leroux B; Jaussaud R; Rémy G; Dupouy D; Millart H; Pinon JM; Urien S
    Br J Clin Pharmacol; 2004 Jun; 57(6):735-41. PubMed ID: 15151519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic disposition of sulfadoxine in children with acute uncomplicated falciparum malaria treated with sulfadoxine-pyrimethamine in South West Nigeria.
    Gbotosho GO; Happi CT; Sijuade A; Sowunmi A; Oduola A
    Am J Ther; 2012 Sep; 19(5):338-45. PubMed ID: 19918170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.
    Obua C; Hellgren U; Ntale M; Gustafsson LL; Ogwal-Okeng JW; Gordi T; Jerling M
    Br J Clin Pharmacol; 2008 Apr; 65(4):493-501. PubMed ID: 18294337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria.
    Bell DJ; Nyirongo SK; Mukaka M; Molyneux ME; Winstanley PA; Ward SA
    Clin Pharmacol Ther; 2011 Feb; 89(2):268-75. PubMed ID: 21191379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.
    Salman S; Griffin S; Kose K; Pitus N; Winmai J; Moore B; Siba P; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1693-700. PubMed ID: 21282434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
    Minzi OM; Gupta A; Haule AF; Kagashe GA; Massele AY; Gustafsson LL
    Eur J Clin Pharmacol; 2007 May; 63(5):457-62. PubMed ID: 17333157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
    Barnes KI; Little F; Smith PJ; Evans A; Watkins WM; White NJ
    Clin Pharmacol Ther; 2006 Dec; 80(6):582-96. PubMed ID: 17178260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.
    Marks F; Evans J; Meyer CG; Browne EN; Flessner C; von Kalckreuth V; Eggelte TA; Horstmann RD; May J
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1101-5. PubMed ID: 15728909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Existence of antimalarial formulations with low bioavailability in Tanzania.
    Minzi OM; Massele A; Justin-Temu M; Ericsson O; Gustafsson LL
    Trop Doct; 2006 Apr; 36(2):93-7. PubMed ID: 16611442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Fansimef components (mefloquine + sulfadoxine + pyrimethamine) in human plasma by two high-performance liquid chromatographic methods.
    Edstein MD; Lika ID; Chongsuphajaisiddhi T; Sabchareon A; Webster HK
    Ther Drug Monit; 1991 Mar; 13(2):146-51. PubMed ID: 2053122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.
    Karunajeewa HA; Salman S; Mueller I; Baiwog F; Gomorrai S; Law I; Page-Sharp M; Rogerson S; Siba P; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4368-76. PubMed ID: 19620325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
    Sarikabhuti B; Keschamrus N; Noeypatimanond S; Weidekamm E; Leimer R; Wernsdorfer W; Kölle EU
    Acta Trop; 1988 Sep; 45(3):217-24. PubMed ID: 2903623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.
    Villena I; Aubert D; Leroux B; Dupouy D; Talmud M; Chemla C; Trenque T; Schmit G; Quereux C; Guenounou M; Pluot M; Bonhomme A; Pinon JM
    Scand J Infect Dis; 1998; 30(3):295-300. PubMed ID: 9790140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 17. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fansidar in the treatment of toxoplasmosis].
    Michalová K; Ríhová E; Havlíková M
    Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of plasma concentration of pyrimethamine (PYR) in infants with congenital Toxoplasma gondii infection--own observations.
    Lipka B; Milewska-Bobula B; Filipek M
    Wiad Parazytol; 2011; 57(2):87-92. PubMed ID: 21682092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W; Teshager G; Zenebe G
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.